KURA vs PCAR · rev $20.9M vs P/E 25, rev $33.66B
Kura Oncology Inc (KURA) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
KURA currently screens at market cap $861.1M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the KURA and PCAR stock pages for the full models.
Not investment advice.